Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Persistence of Primary MALT Lymphoma of the Urinary Bladder after Rituximab with CHOP Chemotherapy and Radiotherapy

JASNA BACALJA, MONIKA ULAMEC, DUJE RAKO, LIDIJA BOŠKOVIĆ, DAVOR TRNSKI, EDUARD VRDOLJAK and BOŽO KRUŠLIN
In Vivo July 2013, 27 (4) 545-549;
JASNA BACALJA
1Department of Pathology, Dubrava University Hospital, Zagreb, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jasnabacalja@yahoo.com
MONIKA ULAMEC
2School of Medicine, University of Zagreb, Zagreb, Croatia
3Ljudevit Jurak Department of Pathology, Sestre Milosrdnice Clinical Hospital Center, Zagreb, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DUJE RAKO
4Department of Urology, Dubrava University Hospital, Zagreb, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LIDIJA BOŠKOVIĆ
6Department of Oncology, Clinical Hospital Center, Split, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAVOR TRNSKI
5Department of Urology, Sestre Milosrdnice Clinical Hospital Center, Zagreb, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EDUARD VRDOLJAK
6Department of Oncology, Clinical Hospital Center, Split, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BOŽO KRUŠLIN
2School of Medicine, University of Zagreb, Zagreb, Croatia
3Ljudevit Jurak Department of Pathology, Sestre Milosrdnice Clinical Hospital Center, Zagreb, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Bladder biopsy showing diffuse dense subepithelial infiltrate of lymphoid cells in the lamina propria (hematoxylin-eosin staining, magnification ×40).

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Infiltrate of the tumour cells was composed of monomorphic small- to medium-sized lymphoid cells, including centrocyte-like cells and plasmacytoid cells (hematoxylin-eosin, original magnification ×400).

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Tumour cells in lamina propria positively stained for CD20 (original magnification ×100).

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Positive immunohistochemical staining for Ki-67 in around 5% of the tumour cells (original magnification ×400).

PreviousNext
Back to top

In this issue

In Vivo: 27 (4)
In Vivo
Vol. 27, Issue 4
July-August 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Persistence of Primary MALT Lymphoma of the Urinary Bladder after Rituximab with CHOP Chemotherapy and Radiotherapy
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Persistence of Primary MALT Lymphoma of the Urinary Bladder after Rituximab with CHOP Chemotherapy and Radiotherapy
JASNA BACALJA, MONIKA ULAMEC, DUJE RAKO, LIDIJA BOŠKOVIĆ, DAVOR TRNSKI, EDUARD VRDOLJAK, BOŽO KRUŠLIN
In Vivo Jul 2013, 27 (4) 545-549;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Persistence of Primary MALT Lymphoma of the Urinary Bladder after Rituximab with CHOP Chemotherapy and Radiotherapy
JASNA BACALJA, MONIKA ULAMEC, DUJE RAKO, LIDIJA BOŠKOVIĆ, DAVOR TRNSKI, EDUARD VRDOLJAK, BOŽO KRUŠLIN
In Vivo Jul 2013, 27 (4) 545-549;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Case Report
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Treatment of Renal Anemia in Patients With Hemodialysis Using Hypoxia-inducible Factor (HIF) Stabilizer, Roxadustat: A Short-term Clinical Study
  • Pediatric Patients With Sickle Cell Disease at a Public Hospital: Nutrition, Compliance and Early Experience With L-Glutamine Therapy
  • Five-year Follow-up of Patients With Head and Neck Cancer Treated With Nivolumab and Long-term Responders for Over Two Years
Show more Clinical Studies

Similar Articles

Keywords

  • MALT lymphoma
  • urinary bladder
  • chemotherapy
  • rituximab
  • CHOP
In Vivo

© 2022 In Vivo

Powered by HighWire